Selective gene-expression profiling of migratory tumor cells in vivo predicts clinical outcome in breast cancer patients
暂无分享,去创建一个
Yarong Wang | Sumanta Goswami | John S Condeelis | P. Kenny | J. Condeelis | S. Goswami | K. Whitney | Yarong Wang | Paraic A Kenny | Antonia Patsialou | Juan Lin | A. Patsialou | Juan Lin | Kathleen Whitney
[1] B. Ross,et al. Molecular Imaging of TGFβ-Induced Smad2/3 Phosphorylation Reveals a Role for Receptor Tyrosine Kinases in Modulating TGFβ Signaling , 2011, Clinical Cancer Research.
[2] Paula D. Bos,et al. Metastasis: from dissemination to organ-specific colonization , 2009, Nature Reviews Cancer.
[3] Pierre Nassoy,et al. MT1-MMP-Dependent Invasion Is Regulated by TI-VAMP/VAMP7 , 2008, Current Biology.
[4] P. Heikkilä,et al. Tumorigenesis and Neoplastic Progression An Extensive Tumor Array Analysis Supports Tumor Suppressive Role for Nucleophosmin in Breast Cancer , 2011 .
[5] W. Muller,et al. Conditional Deletion of Shp2 in the Mammary Gland Leads to Impaired Lobulo-alveolar Outgrowth and Attenuated Stat5 Activation* , 2006, Journal of Biological Chemistry.
[6] Jeffrey M. Rosen,et al. Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features , 2009, Proceedings of the National Academy of Sciences.
[7] C. Heldin,et al. The regulation of TGFβ signal transduction , 2009, Development.
[8] R. Eils,et al. Systemic spread is an early step in breast cancer. , 2008, Cancer cell.
[9] Kakajan Komurov,et al. Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes , 2010, Proceedings of the National Academy of Sciences.
[10] J. Segall,et al. Coordinated regulation of pathways for enhanced cell motility and chemotaxis is conserved in rat and mouse mammary tumors. , 2007, Cancer research.
[11] G. Stamatoyannopoulos,et al. FKLF, a Novel Krüppel-Like Factor That Activates Human Embryonic and Fetal β-Like Globin Genes , 1999, Molecular and Cellular Biology.
[12] John S. Condeelis,et al. Chemotaxis in cancer , 2011, Nature Reviews Cancer.
[13] C. Caldas,et al. Molecular classification and molecular forecasting of breast cancer: ready for clinical application? , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] Jeffrey Wyckoff,et al. Probing the Microenvironment of Mammary Tumors Using Multiphoton Microscopy , 2006, Journal of Mammary Gland Biology and Neoplasia.
[15] W. Qi,et al. NSC348884, a nucleophosmin inhibitor disrupts oligomer formation and induces apoptosis in human cancer cells , 2008, Oncogene.
[16] E. Sahai,et al. Imaging amoeboid cancer cell motility in vivo , 2008, Journal of microscopy.
[17] E. Bottinger,et al. Gene expression analysis on small numbers of invasive cells collected by chemotaxis from primary mammary tumors of the mouse , 2003, BMC biotechnology.
[18] R. Harland,et al. Dazap2 is required for FGF-mediated posterior neural patterning, independent of Wnt and Cdx function. , 2009, Developmental biology.
[19] Vandana Iyer,et al. Estrogen promotes ER-negative tumor growth and angiogenesis through mobilization of bone marrow-derived monocytes. , 2012, Cancer research.
[20] Van,et al. A gene-expression signature as a predictor of survival in breast cancer. , 2002, The New England journal of medicine.
[21] C. Cordon-Cardo,et al. A multigenic program mediating breast cancer metastasis to bone. , 2003, Cancer cell.
[22] D. Laune,et al. Oestrogen receptor negative breast cancers exhibit high cytokine content , 2007, Breast Cancer Research.
[23] Erik Sahai,et al. Localised and reversible TGFβ signalling switches breast cancer cells from cohesive to single cell motility , 2009, Nature Cell Biology.
[24] J. Foekens,et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer , 2005, The Lancet.
[25] Y. Okada,et al. Recruitment of phosphorylated NPM1 to sites of DNA damage through RNF8-dependent ubiquitin conjugates. , 2010, Cancer research.
[26] Y. Agazie,et al. SHP2 is up‐regulated in breast cancer cells and in infiltrating ductal carcinoma of the breast, implying its involvement in breast oncogenesis , 2008, Histopathology.
[27] Mark T. W. Ebbert,et al. Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes , 2011, Nature Medicine.
[28] S. Sleijfer,et al. Medical oncology: clinical value of circulating tumor cells in breast cancer. , 2011, Nature Reviews Clinical Oncology.
[29] F. Modugno,et al. Identification of invasion specific splice variants of the cytoskeletal protein Mena present in mammary tumor cells during invasion in vivo , 2008, Clinical & Experimental Metastasis.
[30] Jeffrey W Pollard,et al. Gene Expression Analysis of Macrophages That Facilitate Tumor Invasion Supports a Role for Wnt-Signaling in Mediating Their Activity in Primary Mammary Tumors , 2009, The Journal of Immunology.
[31] Jeffrey Wyckoff,et al. Invasion of human breast cancer cells in vivo requires both paracrine and autocrine loops involving the colony-stimulating factor-1 receptor. , 2009, Cancer research.
[32] M. Barcellos-Hoff,et al. TGF-beta biology in mammary development and breast cancer. , 2011, Cold Spring Harbor perspectives in biology.
[33] Clifford A. Meyer,et al. MYC regulation of a “poor-prognosis” metastatic cancer cell state , 2010, Proceedings of the National Academy of Sciences.
[34] Alex E. Lash,et al. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..
[35] Robert A. Weinberg,et al. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. , 2008, Developmental cell.
[36] John S. Condeelis,et al. Identification and Testing of a Gene Expression Signature of Invasive Carcinoma Cells within Primary Mammary Tumors , 2004, Cancer Research.
[37] R. Andrews,et al. Mutant nucleophosmin and cooperating pathways drive leukemia initiation and progression in mice , 2011, Nature Genetics.
[38] B. Falini,et al. Acute myeloid leukemia with mutated nucleophosmin (NPM1): any hope for a targeted therapy? , 2011, Blood reviews.
[39] A. Vincent-Salomon,et al. A New Model of Patient Tumor-Derived Breast Cancer Xenografts for Preclinical Assays , 2007, Clinical Cancer Research.
[40] D. Melton,et al. "Stemness": Transcriptional Profiling of Embryonic and Adult Stem Cells , 2002, Science.
[41] R. Puri,et al. Gene expression in human embryonic stem cell lines: unique molecular signature. , 2004, Blood.
[42] T. Matozaki,et al. Protein tyrosine phosphatase SHP‐2: A proto‐oncogene product that promotes Ras activation , 2009, Cancer science.
[43] D. Waugh,et al. The Interleukin-8 Pathway in Cancer , 2008, Clinical Cancer Research.
[44] B. Neel,et al. The tyrosine phosphatase Shp2 (PTPN11) in cancer , 2008, Cancer and Metastasis Reviews.
[45] E. Repasky,et al. Growth and metastasis of surgical specimens of human breast carcinomas in SCID mice. , 1996, The cancer journal from Scientific American.
[46] P G Pelicci,et al. Nucleophosmin and its complex network: a possible therapeutic target in hematological diseases , 2011, Oncogene.
[47] J. Pollard,et al. A Paracrine Loop between Tumor Cells and Macrophages Is Required for Tumor Cell Migration in Mammary Tumors , 2004, Cancer Research.
[48] S. Spiegel,et al. The nuclear matrix protein, numatrin (B23), is associated with growth factor-induced mitogenesis in Swiss 3T3 fibroblasts and with T lymphocyte proliferation stimulated by lectins and anti-T cell antigen receptor antibody , 1988, The Journal of cell biology.
[49] Robert A. Weinberg,et al. Tumor Metastasis: Molecular Insights and Evolving Paradigms , 2011, Cell.
[50] M. Huang,et al. A small-molecule c-Myc inhibitor, 10058-F4, induces cell-cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia. , 2006, Experimental hematology.
[51] Klaus Pantel,et al. Circulating tumour cells in cancer patients: challenges and perspectives. , 2010, Trends in molecular medicine.
[52] J. Segall,et al. In vivo assay for tumor cell invasion. , 2009, Methods in molecular biology.
[53] R. Tibshirani,et al. Repeated observation of breast tumor subtypes in independent gene expression data sets , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[54] J. Condeelis,et al. Arg/Abl2 promotes invasion and attenuates proliferation of breast cancer in vivo , 2012, Oncogene.
[55] W. Gerald,et al. Genes that mediate breast cancer metastasis to the brain , 2009, Nature.
[56] J. Sparano,et al. Clinical application of gene expression profiling in breast cancer. , 2010, Surgical oncology clinics of North America.
[57] E. van Marck,et al. Increased Serum Interleukin-8 in Patients with Early and Metastatic Breast Cancer Correlates with Early Dissemination and Survival , 2004, Clinical Cancer Research.
[58] Ash A. Alizadeh,et al. Gene Expression Signature of Fibroblast Serum Response Predicts Human Cancer Progression: Similarities between Tumors and Wounds , 2004, PLoS biology.
[59] Bernard Ducommun,et al. CDC25 phosphatases in cancer cells: key players? Good targets? , 2007, Nature Reviews Cancer.
[60] Zhiyuan Hu,et al. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors , 2007, Genome Biology.
[61] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[62] Alison Stopeck,et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. , 2004, The New England journal of medicine.
[63] W. Guida,et al. Discovery of a Novel Shp2 Protein Tyrosine Phosphatase Inhibitor , 2006, Molecular Pharmacology.
[64] Yudong D. He,et al. Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.
[65] R. Tibshirani,et al. Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[66] R. Beauchamp,et al. A specific inhibitor of TGF-beta receptor kinase, SB-431542, as a potent antitumor agent for human cancers. , 2005, Neoplasia.
[67] G. Sherlock,et al. The prognostic role of a gene signature from tumorigenic breast-cancer cells. , 2007, The New England journal of medicine.
[68] J. Fuxe,et al. Transcriptional crosstalk between TGFβ and stem cell pathways in tumor cell invasion: Role of EMT promoting Smad complexes , 2010, Cell cycle.
[69] L. Shaw,et al. SHP2 Mediates the Localized Activation of Fyn Downstream of the α6β4 Integrin To Promote Carcinoma Invasion , 2010, Molecular and Cellular Biology.
[70] J. Segall,et al. A critical step in metastasis: in vivo analysis of intravasation at the primary tumor. , 2000, Cancer research.
[71] J. Segall,et al. The collection of the motile population of cells from a living tumor. , 2000, Cancer research.
[72] A. Regev,et al. An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors , 2008, Nature Genetics.
[73] C. Daniel,et al. Reversible inhibition of mammary gland growth by transforming growth factor-beta. , 1987, Science.
[74] Wen-Lin Kuo,et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. , 2006, Cancer cell.
[75] Eran Segal,et al. Module map of stem cell genes guides creation of epithelial cancer stem cells. , 2008, Cell stem cell.
[76] David Venet,et al. Most Random Gene Expression Signatures Are Significantly Associated with Breast Cancer Outcome , 2011, PLoS Comput. Biol..
[77] F. Bertucci,et al. Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. , 2009, Cancer research.
[78] E. Sahai,et al. RHO–GTPases and cancer , 2002, Nature Reviews Cancer.
[79] Ying Lin,et al. Interleukin‐8 modulates growth and invasiveness of estrogen receptor‐negative breast cancer cells , 2007, International journal of cancer.
[80] J. Condeelis,et al. Breast Cancer Cells Isolated by Chemotaxis from Primary Tumors Show Increased Survival and Resistance to Chemotherapy , 2004, Cancer Research.
[81] M. Daly,et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.
[82] Stephen J. Elledge,et al. Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loop , 2012, Nature Medicine.
[83] A. Lucas,et al. IL-8 expression and its possible relationship with estrogen-receptor-negative status of breast cancer cells , 2003, Oncogene.
[84] D. Lauffenburger,et al. Mena invasive (MenaINV) promotes multicellular streaming motility and transendothelial migration in a mouse model of breast cancer , 2011, Journal of Cell Science.
[85] Dennis B. Troup,et al. NCBI GEO: archive for functional genomics data sets—10 years on , 2010, Nucleic Acids Res..
[86] Larry Norton,et al. Tumor Self-Seeding by Circulating Cancer Cells , 2009, Cell.
[87] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[88] Alison Stopeck,et al. Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[89] D. Birnbaum,et al. CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts. , 2010, The Journal of clinical investigation.
[90] A. Partin,et al. Monoclonal antibody to prostate cancer nuclear matrix protein (PRO:4‐216) recognizes nucleophosmin/B23 , 1999, The Prostate.
[91] Andy J. Minn,et al. Genes that mediate breast cancer metastasis to lung , 2005, Nature.
[92] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.